Aminocaproic acid
生产企业:Xanodyne pharmaceutics inc, Abraxis pharmaceutical products,另有 4 家
Aminocaproic acid is an antifibrinolytic agent used to induce clotting postoperatively.
Aminocaproic acid is an antifibrinolytic agent used to induce clotting postoperatively.
Aminocaproic acid binds reversibly to the kringle domain of plasminogen and blocks the binding of plasminogen to fibrin and its activation to plasmin. With NO activation of plasmin, there is a reduction in fibrinolysis. This consequently will reduce the amount of bleeding post surgery. Elevated plasma levels of lipoprotein(a) have been shown to increase the risk of vascular disease. Lipoprotein 9a)a has two components, apolipoprotein B-100, linked to apolipoprotein (a). Aminocaproic acid may change the conformation of apoliprotein (a), changing its binding properties and potentially preventing the formation of lipoprotein (a).
For use in the treatment of excessive postoperative bleeding.
共 1 项相关疾病
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。